Jump to content

Imuracetam: Difference between revisions

Page 1
Page 2
Content deleted Content added
CheMoBot (talk | contribs)
Updating {{chembox}} (no changed fields - added verified revid - updated 'DrugBank_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Wikipedia_talk:W
m corrected primes
 
(15 intermediate revisions by 12 users not shown)
Line 1: Line 1:
{{chembox
{{chembox
| Watchedfields = changed
| UNII_Ref = {{fdacite|correct|FDA}}
| verifiedrevid = 444589978
| UNII = 972FNV35ZM
| ImageFile = Imuracetam Structure.svg
| verifiedrevid = 437173420
| ImageFile = Imuracetam.png
| ImageSize = 140px
| ImageSize = 140px
| IUPACName = ''N'',''N'''-''bis''[(2-oxopyrrolidin-1-yl)methyl]urea
| PIN = ''N'',''N''-Bis[(2-oxopyrrolidin-1-yl)methyl]urea
| OtherNames =
| OtherNames =
| Section1 = {{Chembox Identifiers
|Section1={{Chembox Identifiers
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 972FNV35ZM
| PubChem = 163319
| PubChem = 163319
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
Line 17: Line 18:
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = WMKONRFEZGAHTE-UHFFFAOYSA-N
| StdInChIKey = WMKONRFEZGAHTE-UHFFFAOYSA-N
| CASNo_Ref = {{cascite|correct|??}}
| CASNo =67542-41-0
| CASNo = 67542-41-0
| ATCCode_prefix =
| ChEMBL = 2106342
| ATCCode_suffix =
| SMILES = O=C(NCN1C(=O)CCC1)NCN2C(=O)CCC2
| SMILES = O=C(NCN1C(=O)CCC1)NCN2C(=O)CCC2
}}
}}
| Section2 = {{Chembox Properties
|Section2={{Chembox Properties
| Formula = | C=11 | H=18 | N=4 | O=3
| C=11 | H=18 | N=4 | O=3
| MolarMass = 254.286 g/mol
| Appearance =
| Appearance =
| Density =
| Density =
| MeltingPt =
| MeltingPtC = 184.5
| MeltingPt_ref= <ref name=Ganellin>{{cite book | title = Dictionary of Pharmacological Agents | volume = 3 | vauthors = Ganellin CR, Triggle DJ | publisher = CRC Press | date = 1996}}</ref>
| BoilingPt =
| BoilingPt =
| Solubility = }}
| Solubility = }}
| Section5 = {{Chembox Pharmacology
|Section5={{Chembox Pharmacology
| AdminRoutes =
| AdminRoutes =
| Bioavail =
| Bioavail =
Line 42: Line 43:
| Legal_AU =
| Legal_AU =
| Legal_CA =
| Legal_CA =
| PregCat =
| Pregnancy_category =
| PregCat_AU =
| Pregnancy_AU =
| PregCat_US = }}
| Pregnancy_US = }}
}}
}}


'''Imuracetam''' is a [[nootropic]] drug of the [[racetam]] family.<ref>Avetisyan SA, Kocharov SL, Azaryan LV, Dzhagatspanyan IA, Melikyan GG. Synthesis and psychotropic activity of new 2-pyrrolidone derivatives. ''Pharmaceutical Chemistry Journal''. 1998; 32(2):55-58.</ref>
'''Imuracetam''' is a drug of the [[racetam]] family.<ref>{{cite journal | vauthors = Avetisyan SA, Kocharov SL, Azaryan LV, Dzhagatspanyan IA, Melikyan GG | title = Synthesis and psychotropic activity of new 2-pyrrolidone derivatives. | journal = Pharmaceutical Chemistry Journal | date = February 1998 | volume = 32 | issue = 2 | pages = 55–8 | doi = 10.1007/BF02464161 | s2cid = 29810469 }}</ref> It was under development in the 1970s, but was never marketed.<ref name=Ganellin/>


==References==
==References==
{{reflist}}
<references/>


{{Racetams}}
{{Racetams}}
Line 56: Line 57:
[[Category:Racetams]]
[[Category:Racetams]]
[[Category:Pyrrolidones]]
[[Category:Pyrrolidones]]
[[Category:Nootropics]]
[[Category:Ureas]]
[[Category:Ureas]]
[[Category:Abandoned drugs]]



{{nervous-system-drug-stub}}
{{nervous-system-drug-stub}}